BILL ANALYSIS                                                                                                                                                                                                    Ó




                   Senate Appropriations Committee Fiscal Summary
                           Senator Christine Kehoe, Chair


          AB 969 (Atkins) - Medi-Cal: clinical laboratory and laboratory 
          services.
          
          Amended: June 26, 2012          Policy Vote: Health 8-0
          Urgency: No                     Mandate: No
          Hearing Date: August 6, 2012                           
          Consultant: Brendan McCarthy    
          
          This bill does not meet the criteria for referral to the 
          Suspense File.
          
          
          Bill Summary: AB 969 would prohibit the Department of Health 
          Care Services from reducing rates paid for laboratory services, 
          based on donations or discounts provided to federally qualified 
          health centers for care of the uninsured.

          Fiscal Impact: The bill is not likely to have a significant 
          impact on Medi-Cal costs for laboratory services. 

          Under current law are regulation, providers of laboratory 
          services for Medi-Cal clients are prohibited from charging more 
          than would be charged to other purchasers. This is referred to 
          as the "best price" regulation and is intended to ensure that 
          Medi-Cal does not pay more than any other payer (such as private 
          health plans or Medicare).

          Federally qualified health centers receive federal grant funding 
          to provide care to the uninsured, among other patients. Under 
          current practice, many laboratories provide free or discounted 
          services to federally qualified health centers. In principle, 
          under the best price regulation, laboratories should extend the 
          same discounts to Medi-Cal. In practice, this has not occurred. 

          The 2012-13 budget imposed a 10 percent budget reduction for 
          laboratory rates in Medi-Cal. As part of the implantation of the 
          rate reduction, the health trailer bill (Committee on Budget, AB 
          1494, Chapter 28, Statutes of 2012) suspended the existing best 
          price regulation for twelve months and directed the Department 
          to develop a new methodology for determining the rates Medi-Cal 
          will pay for laboratory services. Under the new methodology, 
          Medi-Cal will pay rates based on the average of what other 








          AB 969 (Atkins)
          Page 1


          payers and other state Medicaid programs are paying for similar 
          services.

          Because the use of the best price regulation has been suspended 
          for twelve months and the Department will develop a new 
          reimbursement methodology that will not be based on the best 
          price, discounts provided to federally qualified health centers 
          would not have an impact on Medi-Cal reimbursement rates.

          If the Department does not implement a new rate methodology 
          within twelve months, the state would return to using the best 
          price regulation. Even if that were to occur, however, it is 
          unlikely that discounts provided to federally qualified health 
          clinics would lead to significant rate reductions for Medi-Cal.

          In practice, it is much more likely that laboratories would 
          increase rates paid by federally qualified health centers rather 
          than extend those low prices to Medi-Cal, which purchases more 
          than $400 million per year for laboratory services.

          Proposed Law: AB 969 would prohibit the Department of Health 
          Care Services from reducing rates paid for laboratory services, 
          based on donations or discounts provided to federally qualified 
          health centers for care of the uninsured.

          Related Legislation: AB 1494 (Committee on Budget, Chapter 28, 
          Statutes of 2012), the budget trailer bill on health, suspended 
          the existing best price regulation for twelve months and 
          directed the Department to develop a new methodology for 
          determining the rates Medi-Cal will pay for laboratory services.

          Staff Comments: In 2008, the Attorney General brought suit 
          against several laboratories, alleging that the laboratories had 
          charged Medi-Cal more for laboratory services than others had 
          been charged. In addition, the Attorney General alleged that 
          laboratories used discounted services to induce providers to 
          refer additional Medi-Cal clients to the laboratories - a form 
          of illegal kickback. The Attorney General recently settled suits 
          against seven laboratories for a total of about $300 million.

          The sponsors of this bill are concerned that with increased 
          focus on rates charged to Medi-Cal under best price regulation, 
          laboratories will begin limiting or eliminate discounted 
          services to federally qualified health centers, rather than 








          AB 969 (Atkins)
          Page 2


          extend those discounts to Medi-Cal.